Results 171 to 180 of about 22,889 (244)

Programmable shunt valves with a "virtual off" for intrathecal chemotherapy delivery in children with high-grade CNS tumors and hydrocephalus. [PDF]

Childs Nerv Syst
Dvir R, Peled Y, Levin D, Elhasid R, Constantini S, Etter MM, Soleman J, Pennacchietti V, Thomale UW, Roth J.   +9 more
europepmc   +1 more source

Learning drug synergy through environment-conditioned feature modulation. [PDF]

Bioinformatics
Jin S, Huang A, Meng Y, Zhu Z, Jiang Y, Xu J, Zeng X.   +6 more
europepmc   +1 more source

Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief Report. [PDF]

JTO Clin Res Rep
Rost M, Fischer R, Reck M, Gauler T, Waller C, Christopoulos P, Hoffknecht P, Jänicke M, Fleitz A, Härzschel A, Lennartz C, Ludwig P, Groth A, Bendel M, Stratmann J, Griesinger F, Thomas M, Eberhardt WEE, Sebastian M.   +18 more
europepmc   +1 more source

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial. [PDF]

Nat Cancer
Yuan G, Lou G, Li J, Xu M, Liu X, Wang D, Zhang K, Zhu T, Li X, Huang Y, Duan W, Wang K, Zhou Q, Li G, Yang C, Zhang J, Sun H, Tang R, Li Q, Wu L.   +19 more
europepmc   +1 more source

Do ethnic differences influence the response to immunotherapy in advanced cervical cancer? [PDF]

Transl Cancer Res
Giannecchini GV, Filgueiras ABT, de Andrade DAP, de Melo AC.   +3 more
europepmc   +1 more source

Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors. [PDF]

NPJ Precis Oncol
Jungwirth G, Paul A, Wöllner A, Warta R, Cao J, Fermi V, Jassowicz L, Dao Trong P, von Deimling A, Debus J, Krieg S, Unterberg A, Abdollahi A, Herold-Mende C.   +13 more
europepmc   +1 more source